SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech - Technical Analysis
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: XenaLives who wrote (26)2/23/2001 11:36:44 AM
From: Jibacoa   of 544
 
Paula:

NEOT: Has in its favor the 51% insiders holding and the fact that there has been additional recent buying by insiders. The short position at 19.7% of the float is also probably a + since they will have to cover some day.<g>

Of course not delving into Neurotrofin's potential. <g>

From a TA point of view, it did pretty well after the buy signal on Jan.31 with volume above 2 million for the day.

Now it has to deal with the resistance at the 5 to 5 1/6 level from the intra-day Hs on Feb.8 and Feb.21. It seems to have good support at the 3 1/4 level.

By the way NUTX is over the Jan., Dec., Oct. and Nov. Hs and seems it will test last year's March H.

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News